E Fund Management Co., Ltd. - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$271
-41.5%
64,520
-16.3%
0.02%
-47.4%
Q4 2022$463
-99.9%
77,101
+2.6%
0.04%
-7.3%
Q3 2022$437,000
+45.7%
75,133
+49.8%
0.04%
+51.9%
Q2 2022$300,00050,1710.03%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders